Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
Cidara Therapeutics (CDTX) Stock Price & Analysis
670 Followers
CDTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.59 - $1.48
Previous Close$0.81
Volume273.90K
Average Volume (3M)693.98K
Market Cap
$75.21M
Enterprise Value$29.09M
Total Cash (Recent Filing)$48.67M
Total Debt (Recent Filing)$4.36M
Price to Earnings (P/E)-2.1
Beta1.38
Next Earnings
May 09, 2024EPS Estimate
-$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding90,433,777
10 Day Avg. Volume1,406,755
30 Day Avg. Volume693,983
Standard Deviation0.23
R-Squared0.05
Alpha-0.00615
Financial Highlights & Ratios
Price to Book (P/B)9.11
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-11.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.29
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.08
Forecast
1Y Price Target
$6.00Price Target Upside622.89% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Cidara Therapeutics News
Ownership Overview
10.57% Insiders
4.60% Mutual Funds
3.77% Other Institutional Investors
81.07% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CDTX FAQ
What was Cidara Therapeutics’s price range in the past 12 months?
Cidara Therapeutics lowest stock price was $0.59 and its highest was $1.48 in the past 12 months.
What is Cidara Therapeutics’s market cap?
Currently, no data Available
When is Cidara Therapeutics’s upcoming earnings report date?
Cidara Therapeutics’s upcoming earnings report date is May 09, 2024 which is in 23 days.
How were Cidara Therapeutics’s earnings last quarter?
Cidara Therapeutics released its earnings results on Feb 28, 2024. The company reported -$0.08 earnings per share for the quarter, beating the consensus estimate of -$0.103 by $0.023.
Is Cidara Therapeutics overvalued?
According to Wall Street analysts Cidara Therapeutics’s price is currently Undervalued.
Does Cidara Therapeutics pay dividends?
Cidara Therapeutics does not currently pay dividends.
What is Cidara Therapeutics’s EPS estimate?
Cidara Therapeutics’s EPS estimate is -$0.07.
How many shares outstanding does Cidara Therapeutics have?
Cidara Therapeutics has 90,619,040 shares outstanding.
What happened to Cidara Therapeutics’s price movement after its last earnings report?
Cidara Therapeutics reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.103. Following the earnings report the stock price went down -1.37%.
Which hedge fund is a major shareholder of Cidara Therapeutics?
Among the largest hedge funds holding Cidara Therapeutics’s share is Fisher Asset Management LLC. It holds Cidara Therapeutics’s shares valued at N/A.
---
Cidara Therapeutics Stock Smart Score
Company Description
Cidara Therapeutics
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Its product pipeline includes Rezafungin and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
---
CDTX Stock 12 Months Forecast
Average Price Target
$6.00
▲(622.89% Upside)
Technical Analysis
Best Analysts Covering CDTX
1 Year
1 Year Success Rate
12/22 ratings generated profit
1 Year Average Return
+18.07%
reiterated a buy rating 8 days ago
Copying Ed Arce's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +18.07% per trade.
---